Trust CO Of Vermont Oncolytics Biotech Inc Transaction History

Trust CO Of Vermont

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$0.85 - $1.59 $4,250 - $7,950	5,000 New	5,000 $5,000
Q1 2022 Apr 05, 2022	SELL	$1.31 - $2.02 $6,550 - $10,100	-5,000 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$1.39 - $2.3 $6,949 - $11,500	5,000 New	5,000 $7,000
Q3 2021 Oct 22, 2021	SELL	$1.93 - $2.77 $9,650 - $13,850	-5,000 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$0.42 - $4.76 $2,100 - $23,800	5,000 New	5,000 $24,000

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $53.8M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Vermont with notifications on news.